C3i Center Inc.
Montreal, QC · Canada
Specialization: Cell and gene therapy CDMO, QC and biomarker lab
Key Differentiator
First Canadian CDMO to get a Health Canada Drug Establishment Licence for commercial cell therapy production.
Core Services
Cell and gene therapy manufacturing; QC release testing; Immune monitoring and biomarker analysis; TCR-beta sequencing; Companion diagnostic development
Capabilities
Market Intelligence
Head office at 5151 de l'Assomption in Montreal. In June 2024 it received a Health Canada DEL for commercial cell therapy drug products.
Website
c3icenter.comSimilar Companies
AGC Biologics
Bothell, WA (US HQ); Boulder, CO; Longmont, CO ·
Proprietary CHEF1® expression system
ARSI Canada Inc.
Mississauga, ON (Unit 16, 6800 Kitimat Rd) · Custom synthesis, analytical development, drug development
Mississauga CRO
Actylis (Montreal Operations)
Quebec ·
Global API and excipient supplier with Canadian manufacturing
Ajinomoto Bio-Pharma Services
San Diego, CA; Oss, Netherlands ·
Proprietary AJICAP™ site-specific ADC bioconjugation technology
Need help finding the right outsourcing partner?
Try AI NavigatorCompany information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.